Aviron Message Board - Msg: 1863110

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aviron

AVIR 3.375

+1.7%

Nov 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Brad C. Dunlap who wrote (49)	7/29/1997 6:46:00 PM
From: Rick Strange	of 645

Brad, I think that what he was talking about when he talked about the vaccine "not being long lasting" was that the components of the vaccine are changed each year based upon the formula of the three dominate strains of flu being forecast by WHO for the coming flu season. This isn't an issue since all vaccine manufactures are in the same boat. What is unique about this vaccine is, as you point out, the nasal spray delivery system and the fact that the cold adapted virus unique to AVIR produces the immune responce but without the flu side effects.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next